166 related articles for article (PubMed ID: 17846137)
21. Synthesis of cidofovir and (S)-HPMPA ether lipid prodrugs.
Beadle JR
Curr Protoc Nucleic Acid Chem; 2007 Jun; Chapter 15():Unit 15.2. PubMed ID: 18428972
[TBL] [Abstract][Full Text] [Related]
22. Treatment of lethal cowpox virus respiratory infections in mice with 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine and its orally active diacetate ester prodrug.
Smee DF; Bailey KW; Sidwell RW
Antiviral Res; 2002 May; 54(2):113-20. PubMed ID: 12062396
[TBL] [Abstract][Full Text] [Related]
23. Treatment of lethal vaccinia virus respiratory infections in mice with cidofovir.
Smee DF; Bailey KW; Sidwell RW
Antivir Chem Chemother; 2001 Jan; 12(1):71-6. PubMed ID: 11437324
[TBL] [Abstract][Full Text] [Related]
24. Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir.
Kern ER; Hartline C; Harden E; Keith K; Rodriguez N; Beadle JR; Hostetler KY
Antimicrob Agents Chemother; 2002 Apr; 46(4):991-5. PubMed ID: 11897580
[TBL] [Abstract][Full Text] [Related]
25. Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses.
Smee DF; Sidwell RW; Kefauver D; Bray M; Huggins JW
Antimicrob Agents Chemother; 2002 May; 46(5):1329-35. PubMed ID: 11959564
[TBL] [Abstract][Full Text] [Related]
26. Cell line dependency for antiviral activity and in vivo efficacy of N-methanocarbathymidine against orthopoxvirus infections in mice.
Smee DF; Wandersee MK; Bailey KW; Wong MH; Chu CK; Gadthula S; Sidwell RW
Antiviral Res; 2007 Jan; 73(1):69-77. PubMed ID: 16712967
[TBL] [Abstract][Full Text] [Related]
27. An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge.
Yang G; Pevear DC; Davies MH; Collett MS; Bailey T; Rippen S; Barone L; Burns C; Rhodes G; Tohan S; Huggins JW; Baker RO; Buller RL; Touchette E; Waller K; Schriewer J; Neyts J; DeClercq E; Jones K; Hruby D; Jordan R
J Virol; 2005 Oct; 79(20):13139-49. PubMed ID: 16189015
[TBL] [Abstract][Full Text] [Related]
28. Effects of cidofovir treatment on cytokine induction in murine models of cowpox and vaccinia virus infection.
Knorr CW; Allen SD; Torres AR; Smee DF
Antiviral Res; 2006 Nov; 72(2):125-33. PubMed ID: 16782209
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of HIV-1 by octadecyloxyethyl esters of (S)-[3-hydroxy-2-(phosphonomethoxy)propyl] nucleosides and evaluation of their mechanism of action.
Magee WC; Valiaeva N; Beadle JR; Richman DD; Hostetler KY; Evans DH
Antimicrob Agents Chemother; 2011 Nov; 55(11):5063-72. PubMed ID: 21896914
[TBL] [Abstract][Full Text] [Related]
30. Octadecyloxyethyl Adefovir Exhibits Potent in vitro and in vivo Cytotoxic Activity and Has Synergistic Effects with Ara-C in Acute Myeloid Leukemia.
Khoury H; He R; Schimmer A; Beadle JR; Hostetler KY; Minden MD
Chemotherapy; 2018; 63(4):225-237. PubMed ID: 30372692
[TBL] [Abstract][Full Text] [Related]
31. Synergistic efficacy of the combination of ST-246 with CMX001 against orthopoxviruses.
Quenelle DC; Prichard MN; Keith KA; Hruby DE; Jordan R; Painter GR; Robertson A; Kern ER
Antimicrob Agents Chemother; 2007 Nov; 51(11):4118-24. PubMed ID: 17724153
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for the treatment of lethal vaccinia virus infections in severe combined immune deficiency (SCID) mice.
Neyts J; De Clercq E
J Med Virol; 1993 Nov; 41(3):242-6. PubMed ID: 8263505
[TBL] [Abstract][Full Text] [Related]
33. Oral activity of ether lipid ester prodrugs of cidofovir against experimental human cytomegalovirus infection.
Bidanset DJ; Beadle JR; Wan WB; Hostetler KY; Kern ER
J Infect Dis; 2004 Aug; 190(3):499-503. PubMed ID: 15243923
[TBL] [Abstract][Full Text] [Related]
34. Antimalarial and toxic effects of the acyclic nucleoside phosphonate (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine in Plasmodium berghei-infected mice.
Smeijsters LJ; Nieuwenhuijs H; Hermsen RC; Dorrestein GM; Franssen FF; Overdulve JP
Antimicrob Agents Chemother; 1996 Jul; 40(7):1584-8. PubMed ID: 8807044
[TBL] [Abstract][Full Text] [Related]
35. Oral 1-O-octadecyl-2-O-benzyl-sn-glycero-3-cidofovir targets the lung and is effective against a lethal respiratory challenge with ectromelia virus in mice.
Hostetler KY; Beadle JR; Trahan J; Aldern KA; Owens G; Schriewer J; Melman L; Buller RM
Antiviral Res; 2007 Mar; 73(3):212-8. PubMed ID: 17123638
[TBL] [Abstract][Full Text] [Related]
36. Increased antiviral activity of 1-O-hexadecyloxypropyl-[2-(14)C]cidofovir in MRC-5 human lung fibroblasts is explained by unique cellular uptake and metabolism.
Aldern KA; Ciesla SL; Winegarden KL; Hostetler KY
Mol Pharmacol; 2003 Mar; 63(3):678-81. PubMed ID: 12606777
[TBL] [Abstract][Full Text] [Related]
37. Cidofovir and (S)-9-[3-hydroxy-(2-phosphonomethoxy)propyl]adenine are highly effective inhibitors of vaccinia virus DNA polymerase when incorporated into the template strand.
Magee WC; Aldern KA; Hostetler KY; Evans DH
Antimicrob Agents Chemother; 2008 Feb; 52(2):586-97. PubMed ID: 18056278
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of delayed treatment with ST-246 given orally against systemic orthopoxvirus infections in mice.
Quenelle DC; Buller RM; Parker S; Keith KA; Hruby DE; Jordan R; Kern ER
Antimicrob Agents Chemother; 2007 Feb; 51(2):689-95. PubMed ID: 17116683
[TBL] [Abstract][Full Text] [Related]
39. Activities of alkoxyalkyl esters of cidofovir (CDV), cyclic CDV, and (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine against orthopoxviruses in cell monolayers and in organotypic cultures.
Lebeau I; Andrei G; Dal Pozzo F; Beadle JR; Hostetler KY; De Clercq E; van den Oord J; Snoeck R
Antimicrob Agents Chemother; 2006 Jul; 50(7):2525-9. PubMed ID: 16801436
[TBL] [Abstract][Full Text] [Related]
40. Ether lipid-ester prodrugs of acyclic nucleoside phosphonates: activity against adenovirus replication in vitro.
Hartline CB; Gustin KM; Wan WB; Ciesla SL; Beadle JR; Hostetler KY; Kern ER
J Infect Dis; 2005 Feb; 191(3):396-9. PubMed ID: 15633099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
